| 1 | Gastrointestinal Neoplasms | 43.6% |
| 2 | Liver neoplasms | 43.6% |
| 3 | Pancreatic Neoplasm | 43.1% |
| 4 | Esophageal Neoplasms | 38.2% |
| 5 | Bile Duct Neoplasms | 32.9% |
| 6 | gallbladder neoplasm | 32.9% |
| 7 | Intestinal Neoplasms | 32.9% |
| 8 | Stomach Neoplasms | 32.9% |
| 9 | Hepatocellular Adenoma | 30.3% |
| 10 | Liver Neoplasms, Experimental | 29.3% |
| 11 | Carcinoma, Pancreatic Ductal | 28.2% |
| 12 | Colorectal Neoplasms | 28.1% |
| 13 | Cecal Neoplasms | 27.6% |
| 14 | Duodenal Neoplasms | 27.6% |
| 15 | Retroperitoneal Neoplasms | 27.4% |
| 16 | Zollinger-Ellison syndrome | 26.5% |
| 17 | Head and Neck Neoplasms | 25% |
| 18 | Soft Tissue Neoplasms | 25% |
| 19 | Thoracic Neoplasms | 25% |
| 20 | insulinoma | 24.7% |
| 21 | Appendiceal Neoplasms | 24.7% |
| 22 | Colonic Neoplasms | 24.7% |
| 23 | Rectal Neoplasms | 24.7% |
| 24 | Gastrinoma | 24.5% |
| 25 | Glucagonoma | 24.5% |
| 26 | Adenomatous Polyposis Coli | 24% |
| 27 | Anus Neoplasms | 23.7% |
| 28 | Sigmoid Neoplasms | 23.7% |
| 29 | Vipoma | 23.5% |
| 30 | Chylous Ascites | 22.2% |
| 31 | Pneumoperitoneum | 22.2% |
| 32 | Mesenteric vascular insufficiency | 21.8% |
| 33 | Mesenteric Vascular Occlusion | 21.6% |
| 34 | Endocrine Gland Neoplasms | 21.4% |
| 35 | Eye Neoplasms | 21.4% |
| 36 | Nervous System Neoplasms | 21.4% |
| 37 | Bone neoplasms | 20.9% |
| 38 | Skin Neoplasms | 20.9% |
| 39 | Hematologic Neoplasms | 20.9% |
| 40 | Parathyroid Neoplasms | 20.7% |
| 41 | Splenic Neoplasms | 20.7% |
| 42 | Thyroid Neoplasm | 20.7% |
| 43 | Thyroid carcinoma | 20.7% |
| 44 | Gastrointestinal Stromal Tumors | 20.3% |
| 45 | Multiple Endocrine Neoplasia | 18.5% |
| 46 | Hemoperitoneum | 18.4% |
| 47 | Mesenteric Panniculitis | 18.4% |
| 48 | Panniculitis, Peritoneal | 18.4% |
| 49 | Peritonitis | 18.4% |
| 50 | Peritoneal Fibrosis | 18.4% |
| 51 | Encapsulating Peritoneal Sclerosis | 18.4% |
| 52 | Tracheal Neoplasms | 18% |
| 53 | Digestive System Neoplasms | 17.9% |
| 54 | Paraneoplastic Encephalomyelitis | 17.8% |
| 55 | Mammary Neoplasms, Experimental | 17.6% |
| 56 | Proctocolitis | 17.2% |
| 57 | Choledochal Cyst | 17.2% |
| 58 | Peritoneal Neoplasms | 17.2% |
| 59 | Biliary Tract Diseases | 17.1% |
| 60 | Gastrointestinal Diseases | 17.1% |
| 61 | Liver diseases | 17.1% |
| 62 | Pancreatic Diseases | 17.1% |
| 63 | Acanthoma | 16.9% |
| 64 | Pancreatic Cyst | 16.3% |
| 65 | Biliary cirrhosis | 15.9% |
| 66 | Pancreatic Fistula | 15.8% |
| 67 | Thyroid Nodule | 15.1% |
| 68 | Carcinoma, Lobular | 14.6% |
| 69 | Duodenitis | 14.4% |
| 70 | Ileitis | 14.4% |
| 71 | Erosive Duodenitis | 14.4% |
| 72 | Hamartoma | 14.3% |
| 73 | Neoplasms, Hormone-Dependent | 14.3% |
| 74 | Neoplasms, Multiple Primary | 14.3% |
| 75 | Paraneoplastic Syndromes | 14.3% |
| 76 | Precancerous Conditions | 14.3% |
| 77 | Neoplasms, Second Primary | 14.3% |
| 78 | Testicular Neoplasms | 14.2% |
| 79 | Barrett Esophagus | 13.8% |
| 80 | Mouth Neoplasms | 13.8% |
| 81 | Central Nervous System Neoplasms | 13.8% |
| 82 | Vascular Neoplasms | 13.8% |
| 83 | Thymus Neoplasms | 13.8% |
| 84 | Esophageal Atresia | 13.7% |
| 85 | Intestinal Atresia | 13.7% |
| 86 | Intestinal Fistula | 13.7% |
| 87 | Enterocutaneous Fistula | 13.7% |
| 88 | Dysentery | 13.6% |
| 89 | Enteritis | 13.6% |
| 90 | Enterocolitis | 13.6% |
| 91 | Esophageal and Gastric Varices | 13.6% |
| 92 | Esophagitis | 13.6% |
| 93 | Gastritis | 13.6% |
| 94 | Genital Neoplasms, Female | 13.6% |
| 95 | Inflammatory Bowel Diseases | 13.6% |
| 96 | Cholecystolithiasis | 13.6% |
| 97 | Breast Neoplasms, Male | 13.6% |
| 98 | Triple Negative Breast Neoplasms | 13.6% |
| 99 | Rectal Fistula | 13.4% |
| 100 | Anal Fistula | 13.4% |
| 101 | Meningioma | 13% |
| 102 | Pouchitis | 12.8% |
| 103 | Multiple Endocrine Neoplasia Type 1 | 12.7% |
| 104 | Thymoma | 12.6% |
| 105 | Abdominal Neoplasms | 12.5% |
| 106 | Colitis | 12.4% |
| 107 | Duodenogastric Reflux | 12.4% |
| 108 | Peptic Ulcer | 12.4% |
| 109 | Proctitis | 12.4% |
| 110 | Choledocholithiasis | 12.4% |
| 111 | Cyst | 11.9% |
| 112 | Neoplastic Processes | 11.9% |
| 113 | Neoplastic Syndromes, Hereditary | 11.9% |
| 114 | Pregnancy Complications, Neoplastic | 11.9% |
| 115 | Adrenal Gland Neoplasms | 11.9% |
| 116 | Genital Neoplasms, Male | 11.9% |
| 117 | Uveal Neoplasms | 11.9% |
| 118 | Acoustic Neuroma | 11.8% |
| 119 | Neoplasms, Experimental | 11.8% |
| 120 | Urologic Neoplasms | 11.8% |
| 121 | Sebaceous Gland Neoplasms | 11.7% |
| 122 | Spinal Neoplasms | 11.7% |
| 123 | Bone Marrow Neoplasms | 11.7% |
| 124 | Fatty Liver, Alcoholic | 11.6% |
| 125 | Hepatitis, Alcoholic | 11.6% |
| 126 | Liver Cirrhosis, Alcoholic | 11.6% |
| 127 | Pancreatic Pseudocyst | 11.4% |
| 128 | Crohn Disease | 11.2% |
| 129 | Duodenal Obstruction | 11.2% |
| 130 | Enterocolitis, Neutropenic | 11.2% |
| 131 | Necrotizing Enterocolitis | 11.2% |
| 132 | Nose Neoplasms | 11.2% |
| 133 | Carcinoma 256, Walker | 11.1% |
| 134 | Bile Duct Diseases | 11.1% |
| 135 | Cholelithiasis | 11.1% |
| 136 | Esophageal Diseases | 11.1% |
| 137 | Fatty Liver | 11.1% |
| 138 | Gastroenteritis | 11.1% |
| 139 | Hepatitis | 11.1% |
| 140 | Portal Hypertension | 11.1% |
| 141 | Intestinal Diseases | 11.1% |
| 142 | Liver Cirrhosis | 11.1% |
| 143 | Pancreatic Insufficiency | 11.1% |
| 144 | Pancreatitis | 11.1% |
| 145 | Stomach Diseases | 11.1% |
| 146 | Focal Nodular Hyperplasia | 11.1% |
| 147 | Hepatic Insufficiency | 11.1% |
| 148 | Steatohepatitis | 11.1% |
| 149 | Palatal Neoplasms | 11% |
| 150 | Leukoplakia, Oral | 11% |
| 151 | Paraneoplastic Cerebellar Degeneration | 10.9% |
| 152 | Duodenal Ulcer | 10.6% |
| 153 | Peptic Ulcer Perforation | 10.6% |
| 154 | Gastric ulcer | 10.6% |
| 155 | Appendicitis | 10.6% |
| 156 | Retinoblastoma | 10.3% |
| 157 | Carcinoma, Ehrlich Tumor | 10.3% |
| 158 | Dermoid Cyst | 10.3% |
| 159 | Carcinoma, Lewis Lung | 10.3% |
| 160 | Pituitary Adenoma | 10.2% |
| 161 | Pituitary Neoplasms | 10.2% |
| 162 | Meningeal Neoplasms | 10.2% |
| 163 | Neoplasms, Radiation-Induced | 10.1% |
| 164 | Melanoma, Experimental | 10% |
| 165 | Leydig Cell Tumor | 10% |
| 166 | Optic Nerve Glioma | 9.9% |
| 167 | Trophoblastic Neoplasms | 9.8% |
| 168 | Colonic Pseudo-Obstruction | 9.8% |
| 169 | Leukemia, Experimental | 9.8% |
| 170 | Nephroblastoma | 9.7% |
| 171 | Limbic Encephalitis | 9.7% |
| 172 | Neoplasms, Neuroepithelial | 9.6% |
| 173 | Gliomatosis cerebri | 9.6% |
| 174 | Enterocolitis, Pseudomembranous | 9.6% |
| 175 | pseudomembranous colitis | 9.6% |
| 176 | Dysentery, Bacillary | 9.6% |
| 177 | Liver Diseases, Parasitic | 9.5% |
| 178 | Tuberous Sclerosis | 9.5% |
| 179 | Hepatic Veno-Occlusive Disease | 9.3% |
| 180 | Peliosis Hepatis | 9.3% |
| 181 | Hepatopulmonary Syndrome | 9.3% |
| 182 | Peutz-Jeghers Syndrome | 9.3% |
| 183 | Colitis, Ischemic | 9.2% |
| 184 | Anus, Imperforate | 9.2% |
| 185 | Gastrointestinal Hemorrhage | 9.2% |
| 186 | Hepatomegaly | 9.2% |
| 187 | Anorectal Malformations | 9.2% |
| 188 | Medulloblastoma | 9.2% |
| 189 | Biliary Fistula | 9.1% |
| 190 | Gastric Fistula | 9.1% |
| 191 | Hepatic Vein Thrombosis | 9.1% |
| 192 | Liver Abscess | 9.1% |
| 193 | Budd-Chiari Syndrome | 9.1% |
| 194 | Tuberculosis, Gastrointestinal | 9.1% |
| 195 | Neuroectodermal Tumors | 9.1% |
| 196 | Liver Abscess, Amebic | 9% |
| 197 | ovarian neoplasm | 9% |
| 198 | Prolactinoma | 8.9% |
| 199 | Growth Hormone-Secreting Pituitary Adenoma | 8.9% |
| 200 | Ear Neoplasms | 8.9% |
| 201 | Eyelid Neoplasms | 8.9% |
| 202 | Lung Neoplasms | 8.9% |
| 203 | Pleural Neoplasms | 8.9% |
| 204 | Lambert-Eaton Myasthenic Syndrome | 8.8% |
| 205 | Sarcoma, Experimental | 8.7% |
| 206 | Brain Neoplasms | 8.7% |
| 207 | Salivary Gland Neoplasms | 8.7% |
| 208 | Spinal Cord Neoplasms | 8.7% |
| 209 | Tongue Neoplasms | 8.7% |
| 210 | melanoma | 8.6% |
| 211 | Uterine Neoplasms | 8.6% |
| 212 | Vaginal Neoplasms | 8.6% |
| 213 | Vulvar Neoplasms | 8.6% |
| 214 | Uterine Cancer | 8.6% |
| 215 | Fallopian Tube Neoplasms | 8.6% |
| 216 | Leukemia, Radiation-Induced | 8.6% |
| 217 | Meningeal Carcinomatosis | 8.4% |
| 218 | Erythroplasia | 8.3% |
| 219 | Follicular cyst | 8.3% |
| 220 | leukemia | 8.3% |
| 221 | Mucocele | 8.3% |
| 222 | Neoplasms, Germ Cell and Embryonal | 8.3% |
| 223 | Neoplasms, Glandular and Epithelial | 8.3% |
| 224 | Pilonidal Cyst | 8.3% |
| 225 | Thyroglossal Cyst | 8.3% |
| 226 | Synovial Cyst | 8.3% |
| 227 | Germ Cell Cancer | 8.3% |
| 228 | Aberrant Crypt Foci | 8.3% |
| 229 | Cecal Diseases | 8.2% |
| 230 | Cholangitis | 8.2% |
| 231 | Cholecystitis | 8.2% |
| 232 | Cholestasis | 8.2% |
| 233 | Colonic Diseases | 8.2% |
| 234 | Common Bile Duct Diseases | 8.2% |
| 235 | Esophageal Stenosis | 8.2% |
| 236 | Hepatitis, Chronic | 8.2% |
| 237 | Ileal Diseases | 8.2% |
| 238 | Intestinal Obstruction | 8.2% |
| 239 | Intestinal Perforation | 8.2% |
| 240 | Jejunal Diseases | 8.2% |
| 241 | Pneumatosis Cystoides Intestinalis | 8.2% |
| 242 | Rectal Diseases | 8.2% |
| 243 | Gastric Dilatation | 8.2% |
| 244 | Liver Failure | 8.2% |
| 245 | Pancreatitis, Chronic | 8.2% |
| 246 | Gastric outlet obstruction | 8.2% |
| 247 | Cronkhite-Canada Syndrome | 8.2% |
| 248 | Non-alcoholic Fatty Liver Disease | 8.2% |
| 249 | Chronic active hepatitis | 8.2% |
| 250 | Intestinal Polyposis | 8.2% |
| 251 | Chemical and Drug Induced Liver Injury | 8% |
| 252 | Opsoclonus-Myoclonus Syndrome | 8% |
| 253 | granulosa cell tumor | 7.9% |
| 254 | Carcinoma, Ovarian Epithelial | 7.9% |
| 255 | Choriocarcinoma | 7.9% |
| 256 | Hepatitis B, Chronic | 7.9% |
| 257 | Hepatitis C, Chronic | 7.9% |
| 258 | Carcinosarcoma | 7.9% |
| 259 | Hemangiosarcoma | 7.9% |
| 260 | Leukemia L1210 | 7.9% |
| 261 | Leukemia P388 | 7.9% |
| 262 | lymphangiosarcoma | 7.9% |
| 263 | Hepatorenal Syndrome | 7.8% |
| 264 | Pharyngeal Neoplasms | 7.8% |
| 265 | Central Nervous System Cysts | 7.7% |
| 266 | Adenoma, Acidophil | 7.6% |
| 267 | Ganglioneuroma | 7.6% |
| 268 | Glioma | 7.6% |
| 269 | Malignant Glioma | 7.6% |
| 270 | Mesoblastic Nephroma | 7.6% |
| 271 | Penile Neoplasms | 7.6% |
| 272 | Prostatic Neoplasms | 7.6% |
| 273 | Polycythemia Vera | 7.5% |
| 274 | Adrenocortical carcinoma | 7.4% |
| 275 | Sarcoma 180 | 7.3% |
| 276 | Bronchial Neoplasms | 7.3% |
| 277 | Multiple Pulmonary Nodules | 7.2% |
| 278 | Myelitis, Transverse | 7.2% |
| 279 | Supratentorial Neoplasms | 7.2% |
| 280 | Carcinoid Tumor | 7.1% |
| 281 | Endometrial Neoplasms | 7.1% |
| 282 | Neurilemmoma | 7.1% |
| 283 | Hutchinson's Melanotic Freckle | 7.1% |
| 284 | Melanoma, Amelanotic | 7.1% |
| 285 | Lymphomatoid Granulomatosis | 7.1% |
| 286 | Esophageal Perforation | 7.1% |
| 287 | Hepatitis, Animal | 7.1% |
| 288 | Hepatitis, Viral, Human | 7.1% |
| 289 | Intestinal Diseases, Parasitic | 7.1% |
| 290 | Cystic Fibrosis | 7% |
| 291 | Leukoplakia | 7% |
| 292 | Lymphocele | 7% |
| 293 | Laryngeal neoplasm | 6.9% |
| 294 | Basal Cell Nevus Syndrome | 6.9% |
| 295 | Breast Cyst | 6.9% |
| 296 | Deglutition Disorders | 6.9% |
| 297 | Histiocytic Disorders, Malignant | 6.9% |
| 298 | Actinic keratosis | 6.9% |
| 299 | Mediastinal Cyst | 6.9% |
| 300 | Neoplasm Invasiveness | 6.9% |
| 301 | Neoplasm Metastasis | 6.9% |
| 302 | Neoplasm Recurrence, Local | 6.9% |
| 303 | Parovarian Cyst | 6.9% |
| 304 | Pericardial Cyst | 6.9% |
| 305 | Thymic Cyst | 6.9% |
| 306 | Carcinogenesis | 6.9% |
| 307 | Myxoid cyst | 6.9% |
| 308 | Metastasis | 6.9% |
| 309 | Porphyrias, Hepatic | 6.8% |
| 310 | Congenital Hyperinsulinism | 6.8% |
| 311 | Achlorhydria | 6.8% |
| 312 | Liver Cirrhosis, Experimental | 6.8% |
| 313 | Gastric Antral Vascular Ectasia | 6.8% |
| 314 | Cholestasis, Extrahepatic | 6.8% |
| 315 | Biliary Dyskinesia | 6.8% |
| 316 | Cholangitis, Sclerosing | 6.8% |
| 317 | Colonic Diseases, Functional | 6.8% |
| 318 | Esophageal motility disorders | 6.8% |
| 319 | Fecal Incontinence | 6.8% |
| 320 | Fecal Impaction | 6.8% |
| 321 | Intussusception | 6.8% |
| 322 | Mallory-Weiss Syndrome | 6.8% |
| 323 | Megacolon | 6.8% |
| 324 | Pyloric Stenosis | 6.8% |
| 325 | Liver Failure, Acute | 6.8% |
| 326 | Acalculous Cholecystitis | 6.8% |
| 327 | End Stage Liver Disease | 6.8% |
| 328 | Ileus | 6.8% |
| 329 | Meconium ileus | 6.8% |
| 330 | Peptic Ulcer Hemorrhage | 6.8% |
| 331 | Gastroparesis | 6.8% |
| 332 | Pancreatitis, Alcoholic | 6.8% |
| 333 | Basal cell carcinoma | 6.7% |
| 334 | Carcinoma, Papillary | 6.7% |
| 335 | Squamous cell carcinoma | 6.7% |
| 336 | Chondrosarcoma | 6.7% |
| 337 | Craniopharyngioma | 6.7% |
| 338 | Cystadenoma | 6.7% |
| 339 | leiomyosarcoma | 6.7% |
| 340 | liposarcoma | 6.7% |
| 341 | Mesothelioma | 6.7% |
| 342 | synovial sarcoma | 6.7% |
| 343 | Neuroectodermal Tumor, Melanotic | 6.7% |
| 344 | Angiomyolipoma | 6.7% |
| 345 | Clear Cell Sarcoma of Soft Tissue | 6.7% |
| 346 | Alveolar Soft Part Sarcoma | 6.7% |
| 347 | Neuroendocrine Tumors | 6.7% |
| 348 | Sarcoma, Myeloid | 6.7% |
| 349 | Carcinoma, Basal Cell | 6.7% |
| 350 | Leukemia, Plasma Cell | 6.7% |
| 351 | Composite Lymphoma | 6.7% |
| 352 | Bladder Neoplasm | 6.7% |
| 353 | Kidney Neoplasm | 6.7% |
| 354 | Ureteral Neoplasms | 6.7% |
| 355 | Urethral Neoplasms | 6.7% |
| 356 | Astrocytoma | 6.6% |
| 357 | Ependymoma | 6.6% |
| 358 | oligodendroglioma | 6.6% |
| 359 | Ganglioglioma | 6.6% |
| 360 | gliosarcoma | 6.6% |
| 361 | Anaplastic astrocytoma | 6.6% |
| 362 | Anaplastic Oligodendroglioma | 6.6% |
| 363 | Renal Cell Carcinoma | 6.6% |
| 364 | Papillary Renal Cell Carcinoma | 6.6% |
| 365 | Brain Stem Neoplasms | 6.4% |
| 366 | Malignant Carcinoid Syndrome | 6.4% |
| 367 | Hypopharyngeal Neoplasms | 6.3% |
| 368 | Pleural Effusion, Malignant | 6.3% |
| 369 | Hypopharyngeal Cancer | 6.3% |
| 370 | Parotid Neoplasms | 6.2% |
| 371 | Prostatic Neoplasms, Castration-Resistant | 6.2% |
| 372 | Nelson Syndrome | 6.2% |
| 373 | Cystadenocarcinoma | 6.2% |
| 374 | Fibrosarcoma | 6.2% |
| 375 | Osteosarcoma | 6.2% |
| 376 | Mucoepidermoid Carcinoma | 6.2% |
| 377 | Glioblastoma | 6.1% |
| 378 | Neuroblastoma | 6.1% |
| 379 | Glioblastoma Multiforme | 6.1% |
| 380 | Massive Hepatic Necrosis | 6.1% |
| 381 | Esophageal Achalasia | 6.1% |
| 382 | Anal Fissure | 6.1% |
| 383 | Intestinal Pseudo-Obstruction | 6.1% |
| 384 | Irritable Bowel Syndrome | 6.1% |
| 385 | Superior Mesenteric Artery Syndrome | 6.1% |
| 386 | Emphysematous Cholecystitis | 6.1% |
| 387 | Neurogenic Bowel | 6.1% |
| 388 | Sphincter of Oddi Dysfunction | 6.1% |
| 389 | Anal Ulcer | 6.1% |
| 390 | Carcinoma, Endometrioid | 6.1% |
| 391 | Choroid Plexus Papilloma | 6% |
| 392 | Ganglioneuroblastoma | 5.9% |
| 393 | Fascioliasis | 5.9% |
| 394 | Lymphoma | 5.9% |
| 395 | Adenofibroma | 5.9% |
| 396 | Fibroadenoma | 5.9% |
| 397 | Malignant Fibrous Histiocytoma | 5.9% |
| 398 | Echinococcosis, Hepatic | 5.9% |
| 399 | Melena | 5.9% |
| 400 | Nasopharyngeal carcinoma | 5.8% |
| 401 | Corpus Luteum Cyst | 5.8% |
| 402 | Ovarian Cysts | 5.8% |
| 403 | Chemical and Drug Induced Liver Injury, Chronic | 5.8% |
| 404 | Reye Syndrome | 5.8% |
| 405 | Hematemesis | 5.8% |
| 406 | Hemorrhoids | 5.7% |
| 407 | Autoimmune hepatitis | 5.7% |
| 408 | Afferent Loop Syndrome | 5.6% |
| 409 | Celiac Disease | 5.6% |
| 410 | Short Bowel Syndrome | 5.6% |
| 411 | Sprue, Tropical | 5.6% |
| 412 | Steatorrhea | 5.6% |
| 413 | Rectocele | 5.6% |
| 414 | Sprue | 5.6% |
| 415 | Diverticulitis | 5.6% |
| 416 | Dumping Syndrome | 5.6% |
| 417 | Rectal Prolapse | 5.6% |
| 418 | Tonsillar Neoplasms | 5.6% |
| 419 | Denys-Drash Syndrome | 5.6% |
| 420 | Bowen's Disease | 5.6% |
| 421 | Paraganglioma | 5.6% |
| 422 | Rhabdomyosarcoma | 5.6% |
| 423 | Giant Cell Tumor of Bone | 5.6% |
| 424 | Cerebellar Neoplasms | 5.6% |
| 425 | Adenoma | 5.5% |
| 426 | Ameloblastoma | 5.5% |
| 427 | Angiokeratoma | 5.5% |
| 428 | Carcinoma | 5.5% |
| 429 | Chordoma | 5.5% |
| 430 | Hemangioma | 5.5% |
| 431 | hemangiopericytoma | 5.5% |
| 432 | Lymphangioma | 5.5% |
| 433 | Mesenchymoma | 5.5% |
| 434 | Nevus | 5.5% |
| 435 | Teratoma | 5.5% |
| 436 | Hepatoblastoma | 5.5% |
| 437 | Mixed Tumor, Mullerian | 5.5% |
| 438 | Germinoma | 5.5% |
| 439 | Teratocarcinoma | 5.5% |
| 440 | Angiofibroma | 5.5% |
| 441 | Sarcoma | 5.5% |
| 442 | Epithelioma | 5.5% |
| 443 | Endometrial Stromal Sarcoma | 5.4% |
| 444 | Carcinoid Heart Disease | 5.3% |
| 445 | Dermatofibrosarcoma | 5.3% |
| 446 | Dermatofibrosarcoma Protuberans | 5.3% |
| 447 | Neurofibrosarcoma | 5.3% |
| 448 | Hydatidiform Mole | 5.2% |
| 449 | Pruritus Ani | 5.1% |
| 450 | Nasopharyngeal Neoplasms | 5% |
| 451 | Hepatitis, Viral, Animal | 5% |
| 452 | Nesidioblastosis | 5% |
| 453 | Variegate Porphyria | 5% |
| 454 | Acute intermittent porphyria | 5% |
| 455 | Porphyria Cutanea Tarda | 5% |
| 456 | Pheochromocytoma | 5% |
| 457 | Alveolar rhabdomyosarcoma | 5% |
| 458 | Lymphangioleiomyomatosis | 5% |
| 459 | Giardiasis | 4.9% |
| 460 | Hepatitis E | 4.9% |
| 461 | Hepatitis B | 4.9% |
| 462 | Hepatitis C | 4.9% |
| 463 | Diverticulum | 4.9% |
| 464 | Hepatitis A | 4.9% |
| 465 | Diverticulosis | 4.9% |
| 466 | Laryngopharyngeal Reflux | 4.8% |
| 467 | Hepatic Encephalopathy | 4.8% |
| 468 | Paranasal Sinus Neoplasms | 4.6% |
| 469 | Plasmacytoma | 4.5% |
| 470 | Malignant histiocytosis | 4.5% |
| 471 | Lymphatic Metastasis | 4.5% |
| 472 | Neoplasms, Unknown Primary | 4.5% |
| 473 | Leukemic Infiltration | 4.5% |
| 474 | Histiocytic sarcoma | 4.5% |
| 475 | Neoplasm Micrometastasis | 4.5% |
| 476 | Lactose Intolerance | 4.2% |
| 477 | Adenocarcinoma | 4.1% |
| 478 | Carcinoma in Situ | 4.1% |
| 479 | Carcinoma, Transitional Cell | 4.1% |
| 480 | Phyllodes Tumor | 4.1% |
| 481 | Dysgerminoma | 4.1% |
| 482 | Hemangioendothelioma | 4.1% |
| 483 | Lipoma | 4.1% |
| 484 | Myoma | 4.1% |
| 485 | Myxoma | 4.1% |
| 486 | Neuroma | 4.1% |
| 487 | Papilloma | 4.1% |
| 488 | Pseudomyxoma Peritonei | 4.1% |
| 489 | Seminoma | 4.1% |
| 490 | Papillomatosis | 4.1% |
| 491 | Angiolipoma | 4.1% |
| 492 | Myelolipoma | 4.1% |
| 493 | Neoplasms, Bone Tissue | 4.1% |
| 494 | Neoplasms, Fibrous Tissue | 4.1% |
| 495 | Smooth Muscle Tumor | 4.1% |
| 496 | Adenomatosis, Pulmonary | 4.1% |
| 497 | Adenomatous Polyps | 4.1% |
| 498 | Carcinoma, Large Cell | 4.1% |
| 499 | Carcinoma, Small Cell | 4.1% |
| 500 | Desmoplastic Small Round Cell Tumor | 4.1% |
| 501 | Chondroma | 4.1% |
| 502 | Enchondroma | 4.1% |
| 503 | Maxillary Sinus Neoplasms | 4% |
| 504 | Hodgkin Disease | 3.8% |
| 505 | Lymphoma, Non-Hodgkin | 3.8% |
| 506 | Polycystic Ovary Syndrome | 3.8% |
| 507 | Zellweger Syndrome | 3.8% |
| 508 | Hepatolenticular Degeneration | 3.5% |
| 509 | Cryptosporidiosis | 3.4% |
| 510 | Adenoid Cystic Carcinoma | 3.4% |
| 511 | fibroma | 3.4% |
| 512 | Fibromatosis | 3.4% |
| 513 | Osteoblastoma | 3.4% |
| 514 | Osteoma | 3.4% |
| 515 | Rhabdomyoma | 3.4% |
| 516 | Xeroderma Pigmentosum | 3.4% |
| 517 | Chondromatosis | 3.4% |
| 518 | Adenocarcinoma, Clear Cell | 3.4% |
| 519 | Cholangiocarcinoma | 3.4% |
| 520 | Cervical Intraepithelial Neoplasia | 3.4% |
| 521 | Hemangioblastoma | 3.4% |
| 522 | Lymphoma, Extranodal NK-T-Cell | 3.4% |
| 523 | Primary amyloidosis | 3.4% |
| 524 | Leukemia, Myelomonocytic, Chronic | 3.4% |
| 525 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.4% |
| 526 | Rift Valley Fever | 3.1% |
| 527 | Fibromatosis, Aggressive | 3% |
| 528 | Fibromatosis, Abdominal | 3% |
| 529 | Klatskin Tumor | 3% |
| 530 | CREST Syndrome | 3% |
| 531 | Mastocytosis | 2.9% |
| 532 | Sturge-Weber Syndrome | 2.9% |
| 533 | Cell Transformation, Viral | 2.9% |
| 534 | Hemangioma, Cavernous | 2.9% |
| 535 | Leukemia, T-Cell | 2.9% |
| 536 | Leukemia, B-Cell | 2.9% |
| 537 | neurofibroma | 2.9% |
| 538 | Lymphoma, Follicular | 2.9% |
| 539 | T-Cell Lymphoma | 2.9% |
| 540 | Mantle cell lymphoma | 2.9% |
| 541 | Mastocytoma | 2.8% |
| 542 | Mastocytosis, Systemic | 2.8% |
| 543 | Leukemia, Myeloid, Chronic-Phase | 2.8% |
| 544 | Waldenstrom Macroglobulinemia | 2.7% |
| 545 | Multiple Myeloma | 2.7% |
| 546 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.4% |
| 547 | Leukemia, Large Granular Lymphocytic | 2.4% |
| 548 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.4% |
| 549 | Lymphoma, T-Cell, Cutaneous | 2.4% |
| 550 | Lymphoma, AIDS-Related | 2.4% |
| 551 | Enteropathy-Associated T-Cell Lymphoma | 2.4% |
| 552 | Primary Effusion Lymphoma | 2.4% |
| 553 | Dupuytren Contracture | 2.2% |
| 554 | Urticaria Pigmentosa | 2.2% |
| 555 | Mycosis Fungoides | 2.1% |
| 556 | Lymphomatoid Papulosis | 2.1% |
| 557 | Plasmablastic lymphoma | 2.1% |
| 558 | Burkitt Lymphoma | 1.8% |
| 559 | Sezary Syndrome | 1.7% |
| 560 | Radicular Cyst | 1.7% |